Jan 08, 2020 9:00am EST CohBar Discovers Novel Peptide Inhibitors of CXCR4, a Key Regulator of Tumor Growth and Metastasis
Dec 16, 2019 9:00am EST CohBar Confirms Anti-fibrotic Effect of a Novel Peptide in a Therapeutic Model of Idiopathic Pulmonary Fibrosis
Nov 05, 2019 9:00am EST CohBar Completes Phase 1a and Initiates Phase 1b Stage of Clinical Trial of CB4211 Under Development for NASH and Obesity
Oct 24, 2019 9:00am EDT CohBar to Announce 2019 Third Quarter Financial Results and Provide Business Update on November 6, 2019
Jul 31, 2019 4:05pm EDT CohBar to Announce 2019 Second Quarter Financial Results and Provide Business Update on August 7, 2019